CryoLife Debt to Equity Ratio 2006-2018 | CRY

Current and historical debt to equity ratio values for CryoLife (CRY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. CryoLife debt/equity for the three months ending September 30, 2018 was 0.78.
CryoLife Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.22B $0.28B 0.78
2018-06-30 $0.22B $0.27B 0.80
2018-03-31 $0.22B $0.28B 0.77
2017-12-31 $0.22B $0.28B 0.79
2017-09-30 $0.07B $0.22B 0.29
2017-06-30 $0.07B $0.22B 0.30
2017-03-31 $0.07B $0.21B 0.31
2016-12-31 $0.07B $0.21B 0.32
2016-09-30 $0.07B $0.20B 0.34
2016-06-30 $0.07B $0.20B 0.36
2016-03-31 $0.07B $0.19B 0.37
2015-12-31 $0.00B $0.16B 0.00
2015-09-30 $0.00B $0.15B 0.00
2015-06-30 $0.00B $0.15B 0.00
2015-03-31 $0.00B $0.15B 0.00
2014-12-31 $0.00B $0.15B 0.00
2014-09-30 $0.00B $0.15B 0.00
2014-06-30 $0.00B $0.15B 0.00
2014-03-31 $0.00B $0.15B 0.00
2013-12-31 $0.00B $0.15B 0.00
2013-09-30 $0.00B $0.14B 0.00
2013-06-30 $0.00B $0.13B 0.00
2013-03-31 $0.00B $0.13B 0.00
2012-12-31 $0.00B $0.13B 0.00
2012-09-30 $0.00B $0.13B 0.00
2012-06-30 $0.00B $0.12B 0.00
2012-03-31 $0.00B $0.12B 0.00
2011-12-31 $0.00B $0.12B 0.00
2011-09-30 $0.00B $0.12B 0.00
2011-06-30 $0.00B $0.12B 0.00
2011-03-31 $0.00B $0.12B 0.00
2010-12-31 $0.00B $0.11B 0.00
2010-09-30 $0.00B $0.11B 0.00
2010-06-30 $0.00B $0.12B 0.00
2010-03-31 $0.00B $0.11B 0.00
2009-12-31 $0.00B $0.11B 0.00
2009-09-30 $0.00B $0.11B 0.00
2009-06-30 $0.00B $0.11B 0.00
2009-03-31 $0.00B $0.10B 0.00
2008-12-31 $0.00B $0.10B 0.00
2008-09-30 $0.00B $0.08B 0.01
2008-06-30 $0.00B $0.07B 0.01
2008-03-31 $0.00B $0.07B 0.01
2007-12-31 $0.00B $0.06B 0.00
2007-09-30 $0.00B $0.06B 0.00
2007-06-30 $0.00B $0.06B 0.00
2007-03-31 $0.00B $0.05B 0.00
2006-12-31 $0.00B $0.05B 0.00
2006-09-30 $0.00B $0.05B 0.00
2006-06-30 $0.00B $0.05B 0.00
2006-03-31 $0.00B $0.05B 0.00
2005-12-31 $0.00B $0.05B 0.00
2005-09-30 $0.00B $0.05B 0.01
2005-06-30 $0.00B $0.05B 0.01
2005-03-31 $0.00B $0.07B 0.01
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.038B $0.190B
CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries. It operates throughout the U.S. and internationally. CryoLife manufactures and distributes BioGlue Surgical Adhesive, an FDA-approved adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals in several other countries throughout the world. CryoLife's BioFoam Surgical Matrix is CE marked in Europe for use as an adjunct to hemostasis in cardiovascular surgery and on abdominal parenchymal tissues (liver and spleen) when control of bleeding by ligature or conventional methods is ineffective or impractical. CryoLife distributes PerClot, a powdered hemostat, in Europe and other select international countries.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $95.443B 22.24
Intuitive Surgical (ISRG) United States $56.884B 55.97
Edwards Lifesciences (EW) United States $33.849B 36.22
Fresenius Medical Care AG KGaA (FMS) Germany $21.878B 14.79
IDEXX Laboratories (IDXX) United States $16.902B 48.28
ABIOMED (ABMD) United States $14.577B 104.74
Hologic (HOLX) United States $12.257B 18.92
Teleflex (TFX) United States $11.825B 26.84
DexCom (DXCM) United States $10.968B 0.00
Varian Medical Systems (VAR) United States $10.888B 27.10
STERIS (STE) United Kingdom $9.726B 25.81
Masimo (MASI) United States $5.732B 37.17
LivaNova (LIVN) United Kingdom $4.683B 30.06
Penumbra (PEN) United States $4.574B 276.21
Globus Medical (GMED) United States $4.485B 28.11
Integra LifeSciences Holdings (IART) United States $4.211B 20.51
Wright Medical Group (WMGI) Netherlands $3.393B 0.00
Cantel Medical (CMD) United States $3.354B 33.08
Inogen (INGN) United States $2.985B 64.43
Integer Holdings (ITGR) United States $2.688B 22.50
Glaukos (GKOS) United States $2.278B 0.00
Halyard Health (AVNS) United States $2.241B 20.19
Tandem Diabetes Care (TNDM) United States $2.018B 0.00
OPKO Health (OPK) United States $1.859B 0.00
Mazor Robotics (MZOR) Israel $1.532B 0.00
Nevro (NVRO) United States $1.265B 0.00
Luminex (LMNX) United States $1.187B 42.95
AxoGen (AXGN) United States $1.131B 0.00
Pacific Biosciences Of California (PACB) United States $1.120B 0.00
Natus Medical (BABY) United States $1.116B 23.44
Orthofix (OFIX) United States $1.069B 30.87
Tactile Systems Technology (TCMD) United States $0.982B 156.41
Intersect ENT (XENT) United States $0.942B 0.00
Mesa Laboratories (MLAB) United States $0.815B 48.18
AngioDynamics (ANGO) United States $0.775B 27.13
Accelerate Diagnostics (AXDX) United States $0.771B 0.00
TransEnterix (TRXC) United States $0.666B 0.00
ViewRay (VRAY) United States $0.631B 0.00
Veracyte (VCYT) United States $0.506B 0.00
SI-BONE INC (SIBN) United States $0.486B 0.00
Sientra (SIEN) United States $0.477B 0.00
OrthoPediatrics (KIDS) United States $0.403B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.393B 0.00
Quotient (QTNT) Switzerland $0.355B 0.00
Neuronetics (STIM) United States $0.350B 0.00
Accuray (ARAY) United States $0.344B 0.00
SeaSpine Holdings (SPNE) United States $0.319B 0.00
Nuvectra (NVTR) United States $0.317B 0.00
Fluidigm (FLDM) United States $0.302B 0.00
IRadimed (IRMD) United States $0.289B 75.51
GenMark Diagnostics (GNMK) United States $0.270B 0.00
Helius Medical Technologies (HSDT) United States $0.262B 0.00
CRH Medical (CRHM) Canada $0.255B 44.00
RTI Surgical (RTIX) United States $0.249B 39.30
Corindus Vascular Robotics (CVRS) United States $0.247B 0.00
Pulse Biosciences (PLSE) United States $0.209B 0.00
T2 Biosystems (TTOO) United States $0.180B 0.00
Ekso Bionics Holdings (EKSO) United States $0.113B 0.00
Ra Medical Systems (RMED) United States $0.112B 0.00
Alphatec Holdings (ATEC) United States $0.105B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.096B 0.00
Sensus Healthcare (SRTS) United States $0.091B 0.00
Apollo Endosurgery (APEN) United States $0.089B 0.00
Second Sight Medical Products (EYES) United States $0.077B 0.00
EDAP TMS (EDAP) France $0.069B 0.00
Biosig Technologies (BSGM) United States $0.065B 0.00
Electromed (ELMD) United States $0.047B 22.72
Xtant Medical Holdings (XTNT) United States $0.045B 0.00
Restoration Robotics (HAIR) United States $0.043B 0.00
Viveve Medical (VIVE) United States $0.042B 0.00
OBALON THERPTCS (OBLN) United States $0.041B 0.00
Vermillion (VRML) United States $0.038B 0.00
ConforMIS (CFMS) United States $0.030B 0.00
Lianluo Smart (LLIT) China $0.029B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.026B 0.00
PAVmed (PAVM) United States $0.026B 0.00
Titan Medical (TMDI) Canada $0.025B 0.00
Dynatronics (DYNT) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.020B 0.00
Neovasc (NVCN) Canada $0.018B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
American Shared Hospital Services (AMS) United States $0.014B 10.61
Bioanalytical Systems (BASI) United States $0.014B 0.00
ENDRA Life Sciences (NDRA) United States $0.011B 0.00
Presbia (LENS) Ireland $0.010B 0.00
Micron Solutions (MICR) United States $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Avinger (AVGR) United States $0.008B 0.00
ReWalk Robotics (RWLK) Israel $0.007B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.007B 0.00
Microbot Medical (MBOT) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Amedica (SINT) United States $0.005B 0.00
EnteroMedics (RSLS) United States $0.001B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00